TP53 and cancer: In GBM, the p53R273H mutation is able to form complexes with factors such as CBP, which can promote histone acetylation, and NFY, which promotes the transcription of mutated p53, thus promoting cancer cell proliferation, invasion, and survival (Huang et al., 2013).